Interesting Image

Late 68Ga PSMA-positive Pancreatic Metastasis From Renal Cell Carcinoma in a Patient with Metastatic Prostate Cancer: A Mission Impossible
  • Gabriela Mateva
  • Nikolina Novoselska
  • Assen Dudov
  • Marina Garcheva-Tsacheva
  • Pavel Bochev
Mol Imaging Radionucl Ther 0; 0: 0-0 [e-Pub] DOI: 10.4274/mirt.galenos.2023.90582
Metastatic Superscan in 18F PSMA PET/CT of a Patient with Prostate Carcinoma
  • Man Mohan Singh
  • Shashwat Verma
  • Lavish Kakkar
  • Satyawati Deswal
  • Priyamedha Bose Thakur
Mol Imaging Radionucl Ther 2024; 33: 38-39 DOI: 10.4274/mirt.galenos.2023.68815 PMID:38390777
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
  • Elahe Pirayesh
  • Mehrdad Tavakoli
Mol Imaging Radionucl Ther 2023; 32: 54-56 DOI: 10.4274/mirt.galenos.2021.55376 PMID:36819190
68Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma
  • Kübra Şahin
  • Ali Kibar
  • Cansu Güneren
  • Muhammet Sait Sağer
  • Kerim Sönmezoğlu
Mol Imaging Radionucl Ther 2024; 33: 54-56 DOI: 10.4274/mirt.galenos.2023.47855 PMID:38390812
Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging
  • Muhammet Sait Sağer
  • Seçkin Bilgiç
  • Lebriz Uslu
  • Sertaç Asa
  • Güneş Sağer
  • Kerim Sönmezoğlu
Mol Imaging Radionucl Ther 2021; 30: 57-59 DOI: 10.4274/mirt.galenos.2019.90532 PMID:33586411
Atypical Presentation of Metastatic Castrate-resistant Prostate Cancer in a Middle Aged African Male with Good Response to Radioligand Therapy
  • Osayande Evbuomwan
  • Walter Endres
  • Tebatso Tebeila
  • Gerrit Engelbrecht
Mol Imaging Radionucl Ther 2024; 33: 57-62 DOI: 10.4274/mirt.galenos.2023.13471 PMID:38390823
Superscan Appearance of 68Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
  • Zehra Pınar Koç
  • Pınar Pelin Özcan
  • Vehbi Erçolak
  • Mehmet Reyhan
Mol Imaging Radionucl Ther 2022; 31: 60-62 DOI: 10.4274/mirt.galenos.2020.78800 PMID:35114754
68Ga PSMA Uptake at Roux-en-Y Eso-jejunostomy Junction Mimicking the Recurrence of Gastric Carcinoma in PET/CT
  • Esra Arslan
  • Tamer Aksoy
  • Merve Cin
  • Coşkun Çakır
  • Fadime Didem Can Trabulus
  • Tevfik Fikret Çermik
Mol Imaging Radionucl Ther 2021; 30: 63-66 DOI: 10.4274/mirt.galenos.2020.86729 PMID:33586413
Comparative Findings Between 68Ga-PSMA and 18F-FDG PET/CT for Hepatocellular Carcinoma
  • Seval Erhamamcı
  • Nesrin Aslan
Mol Imaging Radionucl Ther 2020; 29: 135-138 DOI: 10.4274/mirt.galenos.2020.50455 PMID:33094578
Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall
  • Çiğdem Soydal
  • Burak Demir
  • Gizem Sütçü
  • Mine Araz
  • Nuriye Özlem Küçük
Mol Imaging Radionucl Ther 2023; 32: 150-152 DOI: 10.4274/mirt.galenos.2023.47550 PMID:37337828
Unexpected Metastatic Localizations of Prostate Cancer Determined by 68Ga PSMA PET/CT: Series of Four Cases
  • Gözde Mütevelizade
  • Ceren Sezgin
  • Gül Gümüşer
  • Elvan Sayit
Mol Imaging Radionucl Ther 2022; 31: 223-226 DOI: 10.4274/mirt.galenos.2021.41033 PMID:36268896
Mild 68Ga PSMA-11 Uptake in Incidental Pituitary Adenoma
  • Ediz Beyhan
  • Özge Erol Fenercioğlu
  • Yeşim Karagöz
  • Nurhan Ergül
  • Tevfik Fikret Çermik
Mol Imaging Radionucl Ther 2022; 31: 244-245 DOI: 10.4274/mirt.galenos.2021.97752 PMID:36268938
Isolated Castrate-resistant Prostate Cancer Metastasis to Both Adrenal Glands Detected on 68Ga PSMA PET/CT
  • Osman Kanatsız
  • Filiz Özülker
  • Tamer Aydın
  • Tamer Özülker
Mol Imaging Radionucl Ther 2023; 32: 244-246 DOI: 10.4274/mirt.galenos.2023.03780 PMID:37870375

Original Article

Relative Efficacy of 225Ac-PSMA-617 and 177Lu-PSMA-617 in Prostate Cancer Based on Subcellular Dosimetry
  • Hwan Lee
Mol Imaging Radionucl Ther 2022; 31: 1-6 DOI: 10.4274/mirt.galenos.2021.63308 PMID:35114745
Care Pathway at a Cancer Center for the Administration of Radiometabolic Therapy with 177Lu-PSMA in Patients with Metastatic Castration-resistant Prostate Cancer
  • Carlos Avila
  • Tatiana Cadavid
  • Maria Cristina Martínez
  • Humberto Varela
  • Nathalie Hernández-Hidalgo
Mol Imaging Radionucl Ther 2024; 33: 28-37 DOI: 10.4274/mirt.galenos.2023.82653 PMID:38390762
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry
  • Levent Kabasakal
  • Türkay Toklu
  • Nami Yeyin
  • Emre Demirci
  • Mohammad Abuqbeitah
  • Meltem Ocak
  • Aslan Aygün
  • Emre Karayel
  • Hüseyin Pehlivanoglu
  • Nalan Alan Selçuk
Mol Imaging Radionucl Ther 2017; 26: 62-68 DOI: 10.4274/mirt.08760 PMID:28613198
68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
  • Cihan Gündoğan
  • Nurhan Ergül
  • Mehmet Semih Çakır
  • Özgür Kılıçkesmez
  • Rıza Umar Gürsu
  • Tamer Aksoy
  • Tevfik Fikret Çermik
Mol Imaging Radionucl Ther 2021; 30: 79-85 DOI: 10.4274/mirt.galenos.2021.92053 PMID:34082503
The Role of Ga-68 PSMA PET/CT Scan on Differentiating of Oligometastatic and High Risk Prostate Cancer
  • Mehmet Erdoğan
  • Emine Elif Özkan
  • Sefa Alperen Öztürk
  • Mustafa Yıldız
  • Sevim Süreyya Şengül
Mol Imaging Radionucl Ther 2020; 29: 98-104 DOI: 10.4274/mirt.galenos.2020.89421 PMID:33094571
Correlation of SUVmax and Apparent Diffusion Coefficient Values Detected by Ga-68 PSMA PET/MRI in Primary Prostate Lesions and Their Significance in Lymph Node Metastasis: Preliminary Results of an On-going Study
  • Lebriz Uslu-Beşli
  • Barış Bakır
  • Sertaç Asa
  • Ekrem Güner
  • Çetin Demirdağ
  • Onur Erdem Şahin
  • Emre Karayel
  • Muhammet Sait Sağer
  • Haluk Burçak Sayman
  • Kerim Sönmezoğlu
Mol Imaging Radionucl Ther 2019; 28: 104-111 DOI: 10.4274/mirt.galenos.2019.63825 PMID:31507143
Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight in 68Ga-PSMA PET/CT?
  • Ayşegül Aksu
  • Gamze Çapa Kaya
Mol Imaging Radionucl Ther 2021; 30: 144-149 DOI: 10.4274/mirt.galenos.2021.59254 PMID:34658229